Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Kay A. Lawton"'
Autor:
Walter E Gall, Kirk Beebe, Kay A Lawton, Klaus-Peter Adam, Matthew W Mitchell, Pamela J Nakhle, John A Ryals, Michael V Milburn, Monica Nannipieri, Stefania Camastra, Andrea Natali, Ele Ferrannini, RISC Study Group
Publikováno v:
PLoS ONE, Vol 5, Iss 5, p e10883 (2010)
Insulin resistance is a risk factor for type 2 diabetes and cardiovascular disease progression. Current diagnostic tests, such as glycemic indicators, have limitations in the early detection of insulin resistant individuals. We searched for novel bio
Externí odkaz:
https://doaj.org/article/7cb34fc25490493d886572aefd77fb51
Autor:
Elizabeth Joseloff, Michael V. Milburn, Diana R. Wetmore, Kay A. Lawton, Marianne S. Muhlebach, John A. Ryals, Lining Guo, Wei Sha, Sara C. Bell
Publikováno v:
Pediatric Pulmonology. 49:463-472
Summary Background Cystic fibrosis (CF) is a multi-system disease affecting multiple organs and cells besides the respiratory system. Metabolomic profiling allows simultaneous detection of biochemicals originating from cells, organs, or exogenous ori
Publikováno v:
Obesity. 21:E561-E570
Objectives A spectrum of disorders including simple steatosis, nonalcoholic steatohepatitis, fibrosis, and cirrhosis is described by nonalcoholic fatty liver disease (NAFLD). With the increased prevalence of obesity, and consequently NAFLD, there is
Autor:
Jacob Wulff, Makoto Yamazaki, Kay A. Lawton, Michael V. Milburn, Naoya Masutomi, Naohisa Tsutsui, Danny C. Alexander, Manami Miyake, Hiroko Sato, John A. Ryals, Klaus-Peter Adam, Lining Guo
Publikováno v:
Toxicology and Applied Pharmacology. 268:79-89
Drug-induced liver injury (DILI) is a significant consideration for drug development. Current preclinical DILI assessment relying on histopathology and clinical chemistry has limitations in sensitivity and discordance with human. To gain insights on
Autor:
Michael V. Milburn, Kay A. Lawton
Publikováno v:
Annual Review of Medicine. 64:291-305
Metabolomics, the global interrogation of the biochemical components in a biological sample, has become an important complement to genomics and proteomics to aid in the understanding of pathophysiology. Major advantages of metabolomics are the size o
Autor:
Matthew W. Mitchell, Kay A. Lawton, Walter Gall, Eric Button, James P. Hathorn, Andrea Natali, Michael V. Milburn, Pamela J Nakhle, Klaus-Peter Adam, Regis Perichon, Jeff Cobb, Ele Ferrannini
Publikováno v:
Journal of Diabetes Science and Technology. 7:100-110
Background: Insulin resistance (IR) can precede the dysglycemic states of prediabetes and type 2 diabetes mellitus (T2DM) by a number of years and is an early marker of risk for metabolic and cardiovascular disease. There is an unmet need for a simpl
Autor:
Michael V. Milburn, Matthew W. Mitchell, Douglas P. Lee, Lining Guo, Joseph M. Pilewski, Elizabeth Joseloff, Diana R. Wetmore, Kay A. Lawton, John A. Ryals
Publikováno v:
The Journal of Biological Chemistry
Cystic fibrosis (CF) is a life-shortening disease caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. To gain an understanding of the epithelial dysfunction associated with CF mutations and discover biomarkers
Autor:
Leslie M. Fischer, Steven H. Zeisel, Michael V. Milburn, Wei Jia, Kerry Ann Da Costa, Wei Sha, Kay A. Lawton, Alvin Berger
Publikováno v:
The FASEB Journal. 24:2962-2975
Choline is an essential nutrient, and deficiency causes liver and muscle dysfunction. Common genetic variations alter the risk of developing organ dysfunction when choline deficient, probably by causing metabolic inefficiencies that should be detecta
Autor:
Klaus-Peter Adam, Jeff Cobb, Robert A. Elverson, Robert L. Wolfert, Margaret M. Sinnott, Eric Button, Andrea D. Eckhart, Bernadette Carr, Kay A. Lawton, Jacob Wulff, Regis Perichon, Matthew W. Mitchell, Ele Ferrannini
Publikováno v:
Journal of diabetes science and technology. 9(1)
Background: The oral glucose tolerance test (OGTT) is the only method to diagnose patients having impaired glucose tolerance (IGT), but its use has diminished considerably in recent years. Metabolomic profiling studies have identified a number of met
Autor:
Kay A, Lawton, Meredith V, Brown, Danny, Alexander, Zhen, Li, Jacob E, Wulff, Robert, Lawson, Matt, Jaffa, Mike V, Milburn, John A, Ryals, Robert, Bowser, Merit E, Cudkowicz, James D, Berry, Robert H, Brown
Publikováno v:
Amyotrophic lateral sclerosisfrontotemporal degeneration. 15(5-6)
Our objective was to identify plasma biomarkers of ALS that can aid in distinguishing patients with ALS from those with disease mimics. In this multi-center study, plasma samples were collected from 172 patients recently diagnosed with ALS, 50 health